COnsultant and Associate Professor Mayo College of Medicine
Oncology
Dr. Prema P. Peethambaram, MD
|
|
Give Review
Prema P. Peethambaram practices Oncology. She studied medicine at Stanley Medical College SMC. She received 14 awards: "Travel Award for Poster", "Outstanding Teacher of the Year", "Intern of the Month Award", "The Travancore Maharani Regent", "Sankeenmarar Memorial Gold Medal", "Eswaran Shakunthala Gold Medal", "Old Student's Association Prize", "The Lady Wellington Prize", "Dr. C. S. Ramarao Gold Medal", "Dr. A. N. K. Menon Gold Medal", "Sri Akkaraju Seetharamaiah and Rammamagaru Memorial Prize", "The Lt. Col. A. Chalmen's Prize", "The Travancore Maharani Regent's Prize" and "Government Gold Medal". Prema P. Peethambaram, MD is a published doctor and has 32 publications published. The lastest was: 'An evaluation of postoperative follow-up tests in colon cancer patients treated for cure.' She accepts all Medicare patients.
Publications
- A phase I pharmacokinetic and safety Analysis of epothilone folate (BMS-753493), a folate receptor targeted chemotherapeutic agent in humans with advanced solid tumors.
- Self-Perceptions of Age among 292 Chemotherapy-Treated Cancer Patients: Exploring Associations with Symptoms and Survival.
- A phase 2 trial of flavopiridol (Alvocidib) and cisplatin in platin-resistant ovarian and primary peritoneal Carcinoma: MC0261.
- Cutaneous presentation of a distant metastasis of malignant phyllodes tumor.
- A phase II study of gemcitabine in combination with tanespimycin in advanced epithelial ovarian and primary peritoneal Carcinoma.
- Assessment of hepatocyte growth factor in ovarian Cancer mortality.
- Phase II trial of lapatinib and topotecan (LapTop) in patients with platinum-refractory/resistant ovarian and primary peritoneal Carcinoma.
- Consumer Beware: A Systematic Assessment of Potential Bias in the Lay Electronic Media to Examine the Portrayal of "PARP" Inhibitors for Cancer Treatment.
- Inherited determinants of ovarian Cancer survival.
- Phase I trial of intraperitoneal administration of an oncolytic measles virus strain engineered to express carcinoembryonic antigen for recurrent ovarian Cancer.
- A phase I trial of immunotherapy with lapuleucel-T (APC8024) in patients with refractory metastatic Tumors that express HER-2/neu.
- Intratumoral administration of a 1,2-dimyristyloxypropyl-3- dimethylhydroxyethyl ammonium bromide/dioleoylphosphatidylethanolamine formulation of the human interleukin...
- Pelvic primitive neuroectodermal tumor associated with a cluster of small round cell Tumors: case report and review of current literature.
- Her-2/neu expression in ovarian Cancer: pre- and postexposure to platinum chemotherapy.
- Second-line and subsequent therapy for ovarian Carcinoma.
- Phase I and pharmacologic study of sequences of gemcitabine and the multitargeted antifolate agent in patients with advanced solid Tumors.
- Polymorphisms in ABCB1 and ERCC2 associated with ovarian Cancer outcome.
- A phase I trial of the novel farnesyl protein transferase inhibitor, BMS-214662, in combination with paclitaxel and carboplatin in patients with advanced Cancer.
- A phase I trial of celecoxib in combination with docetaxel and irinotecan in patients with advanced Cancer.
- Very high levels of soluble CD30 recognize the patients with classical Hodgkin''s Lymphoma retaining a very poor prognosis.
- Are Cancer survivors/patients knowledgeable about osteoporosis? Results from a survey of 285 chemotherapy-treated Cancer patients and their companions.
- Centering prayer for women receiving chemotherapy for recurrent ovarian Cancer: a pilot study.
- A Phase II trial of aprinocarsen, an antisense oligonucleotide inhibitor of protein kinase C alpha, administered as a 21-day infusion to patients with advanced Ovarian...
- Elevated serum levels of IL-10 are associated with inferior progression-free survival in patients with Hodgkin''s Disease treated with radiotherapy.
- Balancing service and education: improving internal medicine residencies in the managed care era.
- An evaluation of postoperative follow-up tests in colon Cancer patients treated for cure.
- Phase II trial of primary chemotherapy followed by reduced-dose radiation for CNS germ cell Tumors.
- Randomized trial of diethylstilbestrol vs. tamoxifen in postmenopausal women with metastatic breast Cancer. An updated analysis.
- Management of menopausal symptoms in breast Cancer patients.
- Phase I trial of autologous hematopoietic SCT with escalating doses of topotecan combined with CY and carboplatin in patients with relapsed or persistent Ovarian or pr...
- Safety of pegfilgrastim (neulasta) in patients with sickle cell trait/Anemia.
Procedures Preformed
- Plasmapheresis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- Travel Award for Poster
- Outstanding Teacher of the Year
- Intern of the Month Award
- The Travancore Maharani Regent
- Sankeenmarar Memorial Gold Medal
- Eswaran Shakunthala Gold Medal
- Old Student's Association Prize
- The Lady Wellington Prize
- Dr. C. S. Ramarao Gold Medal
- Dr. A. N. K. Menon Gold Medal
- Sri Akkaraju Seetharamaiah and Rammamagaru Memorial Prize
- The Lt. Col. A. Chalmen's Prize
- The Travancore Maharani Regent's Prize
- Government Gold Medal
Education
-
Mayo School of Graduate Medical Education -
Henry Ford Hospital - Wayne State University -
Stanley Medical College SMC
Hospital
-
Mayo Clinic - Rochester, Minnesota
Drug Facts
| NPI NUMBER | 1760460505 | |
| NPPES Provider LastName | PEETHAMBARAM | |
| NPPES Provider FirstName | PREMA | |
| NPPES Provider ZIPCode | 559050001 | |
| NPPES Provider State | MN | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 467.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1760460505 |
| Last Name Of The Provider | PEETHAMBARAM |
| First Name Of The Provider | PREMA |
| View All |
Similar Doctors
|
|
Dr. S Vincent Rajkumar, MD |
|
|
Dr. C Christopher Hook, MD |
|
|
Dr. Harry H. Yoon, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Animesh D. Pardanani, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Edward T. Creagan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph Rubin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James N. Ingle, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Syed T. Mahmood, MD |
|
|
Dr. William G. Morice, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kostandinos Sideras, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michelle A. Elliott, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. David J. Inwards, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Mary M. Gallenberg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Timothy J. Moynihan, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Dennis A. Gastineau, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Jeremy C. Jones, MD |